A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...

Sydney scientists have revealed why receiving a booster vaccine in the same arm as your first dose can generate a more ...

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

A fundamental discovery in how the immune system organizes itself to respond better to external threats,” researchers find in study.

During a major phase III trial, pembrolizumab combined with standard treatment kept cancer at bay for an average of 60 months ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

In advanced head and neck squamous cell carcinoma, evorpacept and Keytruda didn’t meet the primary endpoints of the ASPEN-03 ...

Many patent applicants currently face difficulty in obtaining antibody claims because of written description and enablement ...